Toro Neurovascular Secures FDA Clearance for First Neurovascular Access Catheter
Published: 23 Mar 2026
Author: Precedence Research
In March 2026, Toro Neurovascular made it public that it has received clearance from the U.S Food and Drug Administration for its Toro 88 Superbore Catheter. This FDA clearance is a significant milestone for the company in the neurovascular market. This milestone paves way for the company to debut in the neurovascular market, a competitive industry where stability is a crucial factor for success.
Toro 88 is a neurovascular access catheter that is intended for use by physicians during complex neurovascular procedures. The device is intended for use during neurovascular procedures, providing access and stability for the physician. The Toro 88 is created with a large inner diameter, providing stability as it moves through complex neurovascular anatomy. It has already been shown in early clinical use that it holds its position and performs reliably in demanding situations.
Focus on Stability and Procedural Control.
Another notable aspect of the Toro 88 is its focus on stability. This is evident in the engineering that has gone into the development of this device. This is important in the neurovascular space because the vessels are often delicate and require the utmost precision. The industry is constantly seeking ways to improve the efficiency and safety of neurovascular interventions.
According to Precedence Research, The global catheter stabilization device market size was calculated at USD 1.92 billion in 2025 and is predicted to increase from USD 2.05 billion in 2026 to approximately USD 3.74 billion by 2035, expanding at a CAGR of 6.90% from 2026 to 2035 as the demand grows for catheters that are properly secured to prevent dislodgement, which could lead to infections during treatment.
Commercialization Backed by Kaneka Corporation
The commercialization of the Toro 88 will be backed by the Kaneka Corporation. The partnership is expected to increase the availability of the product and tap into the existing expertise in the field of medical technology. With the launch of the product, Toro Neurovascular is ready to take on the neurovascular field, which is expected to witness a surge in innovation with the increasing need for minimally invasive surgeries. Overall, this development illustrates how improvements in catheters are beginning to take account of stabilizing factors, which is where the future of interventional devices is headed.
A recent report by Precedence Research highlights that the catheter stabilization device market is benefiting from advancements in adhesive technology and design innovations for improved patient comfort.